We don't charge dispensing fee
Shipped and delivered directly to your doorstep
Votrient (geneically known as pazopanib) is an oral medication indicated to treat certain types of cancer. It is indicated for the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer, and advanced soft tissue sarcoma (STS), a type of cancer that affects the body’s connective tissues, such as muscles, tendons, and cartilage.
Votrient is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that help to control the growth and division of cells. Votrient blocks several tyrosine kinases on the surface of cancer cells, as well as targets within the cell. By blocking these signals, Votrient can help slow or stop the growth of cancer cells. Additionally, Votrient is thought to work, in part, by blocking the growth of new blood vessels that support tumor growth.
Votrient is typically prescribed to patients who have already received prior chemotherapy. It is approved for the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. It should be taken exactly as prescribed by the healthcare provider.
Pazopanib is usually taken once a day by mouth as a tablet on an empty stomach, at least 1 hour before or 2 hours after a meal. Do not crush, chew, or split the tablets and take them with plenty of water. Take the medication at the same time every day and follow the directions on your prescription label carefully.
The recommended dose of pazopanib varies depending on the condition being treated and the individual patient’s circumstances.
Your doctor may adjust your dose or discontinue the treatment depending on how well the medication is working and any side effects may experience. Continue taking pazopanib even if you feel fine and do not stop taking it without consulting with your doctor. Talk to your doctor about your progress during treatment.
Votrient (Pazopanib Hcl) is available in the following forms and strength:
Votrient is not a chemotherapy drug but one of many “targeted therapies.” Targeted therapy is the result of about 100 years of research dedicated to understanding the differences between cancer cells and normal cells.
Votrient stays in your system for approximately 5 to 6.5 days. This estimate is based on the half-life of Votrient which is about 31 hours and experts agree that it takes up to 5 half-lives for a drug without active metabolites to be completely removed from the body.
Pazopanib can cause life-threatening blood clots in the small blood vessels inside your organs, such as your brain or kidneys.
Generic name: | Pazopanib Hcl |
---|---|
Formulation: | Tablet |
Strength(s): | 400mg |
Quantities Available: | 30 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Votrient (Pazopanib Hcl). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Votrient (Pazopanib Hcl).
REVIEWS